National and subnational burden of brain and central nervous system cancers in Iran, 1990–2019: Results from the global burden of disease study 2019
Cancer Medicine · 2023
DOI: 10.1002/cam4.5553 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Mahdi Mahdavi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran,…. Hauptthemen laut MEDLINE: Global Burden of Disease, Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Central nervous system cancers (CNS cancers) impose a significant burden upon healthcare systems worldwide. Currently, the lack of a comprehensive study to assess various epidemiological indexes of CNS cancers on national and subnational scales in Iran can hamper healthcare planning and resource allocation in this regard. This study aims to fill this gap by providing estimates of CNS cancer epidemiological measures on national and subnational levels in Iran from 1990 to 2019. Materials and Methods This study is a part of Global Burden of Disease (GBD) 2019 that contains epidemiological measures including prevalence, incidence, mortality, Disability‐Adjusted Life Years (DALYs), Years Lived with Disability (YLDs), and Years of Life Lost (YLLs) of CNS cancers. Age standardization was utilized for comparing different provinces.
Results
In 2019, 5811 (95% Uncertainty Interval: 2942–7046) national new cases and 3494 (1751–4173) deaths due to CNS cancers were reported. National age‐standardized incidence (ASIR), deaths (ASDR), and DALYs rates were 7.3 (3.7–8.8), 4.6 (2.3–5.5), and 156.4 (82.0–187.0) per 100,000 in 2019, respectively. Subnational results revealed that ASDR and ASIR have increased in the past 30 years in all provinces. Although incidence rates have increased in all age groups and genders since 1990, death rates have remained the same for most age groups and genders except for young patients aged under 15, where a decrease in mortality and YLLs can be observed.
Conclusion
The incidence, deaths, and DALYs of CNS cancers increased at national and subnational levels. These findings should be considered for planning and resource allocation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
- Institute of Medical Science and Technology (IMSAT), Shahid Beheshti University, Tehran, Iran.
- Kiel Institute for the World Economy, Kiel, Germany.
- Department of Neurological Surgery, University of Oklahoma Health Sciences Center, Oklahoma, Oklahoma, USA.
- Department of Neurosurgery, Loghman Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Mahdi Mahdavi, Sahar Saeedi Moghaddam, Farzad Kompani
Zitieren
APA
Mahdavi, M., Moghaddam, S. S., Abbasi-Kangevari, M., Mohammadi, E., Shobeiri, P., Sharifi, G., Jafari, A., Rezaei, N., Ebrahimi, N., Rezaei, N., Ghamari, S. H., Malekpour, M. R., Khalili, M., Larijani, B., & Kompani, F. (2023). National and subnational burden of brain and central nervous system cancers in Iran, 1990–2019: Results from the global burden of disease study 2019. Cancer Medicine. https://doi.org/10.1002/cam4.5553
Vancouver
Mahdavi M, Moghaddam SS, Abbasi-Kangevari M, Mohammadi E, Shobeiri P, Sharifi G, et al. National and subnational burden of brain and central nervous system cancers in Iran, 1990–2019: Results from the global burden of disease study 2019. Cancer Medicine. 2023. doi:10.1002/cam4.5553
BibTeX
@article{Mahdavi2023,
author = {Mahdavi, Mahdi and Moghaddam, Sahar Saeedi and Abbasi-Kangevari, Mohsen and Mohammadi, Esmaeil and Shobeiri, Parnian and Sharifi, Guive and Jafari, Ali and Rezaei, Negar and Ebrahimi, Narges and Rezaei, Nazila and Ghamari, Seyyed-Hadi and Malekpour, Mohammad-Reza and Khalili, Majid and Larijani, Bagher and Kompani, Farzad},
title = {National and subnational burden of brain and central nervous system cancers in Iran, 1990–2019: Results from the global burden of disease study 2019},
journal = {Cancer Medicine},
year = {2023},
doi = {10.1002/cam4.5553}
}
EUVIMED